Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

MBCProject_3947_T1_RNA

· A

5c6f1a5b-6d3e-5abf-9424-67b82088e88e

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
A
subtype
A

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • UV_RESPONSE_DN+0.330
  • PROTEIN_SECRETION+0.190
  • HEDGEHOG_SIGNALING+0.160
  • KRAS_SIGNALING_UP+0.130
  • NOTCH_SIGNALING+0.130
  • FATTY_ACID_METABOLISM+0.080
  • WNT_BETA_CATENIN_SIGNALING+0.060
  • PANCREAS_BETA_CELLS+0.050
  • ANDROGEN_RESPONSE-0.010
  • SPERMATOGENESIS-0.030

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.500
  • G2M_CHECKPOINT-0.490
  • E2F_TARGETS-0.460
  • MTORC1_SIGNALING-0.430
  • MYC_TARGETS_V2-0.420
  • INTERFERON_GAMMA_RESPONSE-0.410
  • UV_RESPONSE_UP-0.390
  • ESTROGEN_RESPONSE_LATE-0.380
  • INFLAMMATORY_RESPONSE-0.350
  • GLYCOLYSIS-0.330

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR6013544
lung-landscapes@6
cohortA10.863
2SRR23303736
bladder-landscape@3
0.860
3MBCProject_0719_T3_RNA
breast-umap@18
A0.855
4ULC0424T_S49
lung-landscapes@6
cohortA10.854
5SRR25617864
breast-umap@18
A0.854
6BSR_17_0022_E1_S60
breast-umap@18
A0.852
7BSR_10_0261_B3_S85
breast-umap@18
A0.851
8dab9a230-f4f6-4692-863a-5fdcf516be24
colon-landscapes@1
0.846
9TCGA-A7-A0DB-01C-02R-A277-07
breast-umap@18
D0.844
10SRR8613752
breast-umap@18
A0.843

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
UV_RESPONSE_DN0.330Inavolisib— uncovered
PROTEIN_SECRETION0.190Remibrutinib— uncovered
HEDGEHOG_SIGNALING0.160Inavolisib— uncovered
KRAS_SIGNALING_UP0.130Inavolisib— uncovered
NOTCH_SIGNALING0.130Inavolisib— uncovered
FATTY_ACID_METABOLISM0.080Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.060Inavolisib— uncovered
PANCREAS_BETA_CELLS0.050Cobimetinib— uncovered